Health Sciences Acquisitions Corp 2 HSAQ
We take great care to ensure that the data presented and summarized in this overview for Health Sciences Acquisitions Corp 2 is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HSAQ
View allLatest Institutional Activity in HSAQ
Top Purchases
Top Sells
About HSAQ
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
Insider Transactions at HSAQ
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2024
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.29%
|
$4,000
$4.83 P/Share
|
|
Dec 18
2024
|
David P Hochman Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.86%
|
$20,000
$4.91 P/Share
|
|
Dec 12
2024
|
Andrew Lawrence Taylor Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,403
-9.09%
|
$172,015
$5.03 P/Share
|
|
Dec 05
2024
|
Darren Sherman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,815
-4.15%
|
$159,075
$5.57 P/Share
|
|
Sep 25
2024
|
David P Hochman Director |
BUY
Open market or private purchase
|
Indirect |
7,500
+37.61%
|
$30,000
$4.76 P/Share
|
|
Sep 24
2024
|
David P Hochman Director |
BUY
Open market or private purchase
|
Direct |
2,500
+0.44%
|
$10,000
$4.91 P/Share
|
|
Sep 10
2024
|
Darren Sherman Director |
SELL
Open market or private sale
|
Direct |
6,904
-0.89%
|
$34,520
$5.31 P/Share
|
|
Sep 10
2024
|
Eric S Fain Director |
SELL
Open market or private sale
|
Indirect |
1,800
-4.19%
|
$9,000
$5.34 P/Share
|
|
Sep 09
2024
|
Darren Sherman Director |
SELL
Open market or private sale
|
Direct |
6,804
-0.87%
|
$34,020
$5.48 P/Share
|
|
Sep 09
2024
|
Eric S Fain Director |
SELL
Open market or private sale
|
Indirect |
1,800
-4.02%
|
$9,000
$5.43 P/Share
|
|
Sep 06
2024
|
Eric S Fain Director |
SELL
Open market or private sale
|
Indirect |
2,000
-4.27%
|
$10,000
$5.64 P/Share
|
|
Sep 06
2024
|
Darren Sherman Director |
SELL
Open market or private sale
|
Direct |
6,819
-0.87%
|
$34,095
$5.65 P/Share
|
|
Sep 05
2024
|
Darren Sherman Director |
SELL
Open market or private sale
|
Direct |
6,961
-0.88%
|
$34,805
$5.85 P/Share
|
|
Sep 04
2024
|
Darren Sherman Director |
SELL
Open market or private sale
|
Direct |
6,837
-0.85%
|
$41,022
$6.1 P/Share
|
|
Aug 14
2024
|
David P Hochman Director |
BUY
Open market or private purchase
|
Direct |
2,500
+0.44%
|
$12,500
$5.84 P/Share
|
|
Aug 07
2024
|
John Prosper Mack Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,864
+50.0%
|
-
|
|
Aug 05
2024
|
Hsac 2 Holdings, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,405,251
-66.63%
|
-
|
|
Jun 25
2024
|
David P Hochman Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.3%
|
$6,000
$6.95 P/Share
|
|
Jun 20
2024
|
David Pacitti Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,376
+23.45%
|
-
|
|
Jun 20
2024
|
Eric S Fain Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,376
+10.3%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 676K shares |
|---|---|
| Open market or private purchase | 23.5K shares |
| Open market or private sale | 39.9K shares |
|---|---|
| Payment of exercise price or tax liability | 66.2K shares |
| Other acquisition or disposition | 3.41M shares |